OBIO® Thought Leadership: How Defence Spending Could Help Canada Beyond the Military

Check out this article published in the Toronto Star, which explains how scaling up dual-use technologies can help bolster domestic supply chains, monitor crops, support environmental initiatives and foster new innovations. Ottawa has earmarked $241 million to support small and mid-sized Canadian companies developing technologies that straddle defence and civilian use.

Dr. Maura Campbell, President and CEO of OBIO®, echoes this sentiment by advocating for a strategic, modernized, innovation‑focused approach that helps Canada build technologies that strengthen both national security and the broader economy. OBIO® supports a wide range of life sciences & health tech companies developing innovative solutions that reflect the potential of dual‑use innovation. Among them, Qidni Labs, Deep Breathe, and Vasomune Therapeutics, are mentioned in the article.